Acknowledgement
The authors are grateful to all staff members, doctors, and statistical consultants who were involved in this study.
References
- DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 2003;348:2656-68. https://doi.org/10.1056/NEJMra022567
- Chinnery PF. Mitochondrial Disorders Overview. 2000 Jun 8 [updated 2014 Aug 14]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021.
- El-Hattab AW, Almannai M, Scaglia F. MELAS. 2001 Feb 27 [updated 2018 Nov 29]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020.
- Koenig MK, Emrick L, Karaa A, Korson M, Scaglia F, Parikh S, et al. Recommendations for the Management of Strokelike Episodes in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes. JAMA Neurol 2016;73:591-4. https://doi.org/10.1001/jamaneurol.2015.5072
- El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab 2015;116:4-12. https://doi.org/10.1016/j.ymgme.2015.06.004
- Morava E, van den Heuvel L, Hol F, de Vries MC, Hogeveen M, Rodenburg RJ, et al. Mitochondrial disease criteria: diagnostic applications in children. Neurology 2006;67:1823-6. https://doi.org/10.1212/01.wnl.0000244435.27645.54
- Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 2008;94:16-37. https://doi.org/10.1016/j.ymgme.2007.11.018
- Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med 2015;17:689-701. https://doi.org/10.1038/gim.2014.177
- Villani GRD, Gallo G, Scolamiero E, Salvatore F, Ruoppolo M. "Classical organic acidurias": diagnosis and pathogenesis. Clin Exp Med 2016;17:305-23. https://doi.org/10.1007/s10238-016-0435-0
- Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, et al. Taro Matsuoka for MELAS Study Group in Japan. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta 2012;1820:619-24. https://doi.org/10.1016/j.bbagen.2011.03.015
- Na JH, Kim HD, Lee YM. Effective and safe diet therapies for Lennox-Gastaut syndrome with mitochondrial dysfunction. Ther Adv Neurol Disord 2020; 13:1756286419897813.
- Chae HW, Na JH, Kim HS, Lee YM. Mitochondrial diabetes and mitochondrial DNA mutation load in MELAS syndrome. Eur J Endocrinol 2020;183:505-12. https://doi.org/10.1530/EJE-20-0189
- Lee HN, Eom S, Kim SH, Kang HC, Lee JS, Kim HD, et al. Epilepsy characteristics and clinical outcome in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Pediatr Neurol 2016;64:59-65. https://doi.org/10.1016/j.pediatrneurol.2016.08.016
- Eom S, Lee HN, Lee S, Kang HC, Lee JS, Kim HD, et al. Cause of death in children with mitochondrial diseases. Pediatr Neurol 2017;66:82-8. https://doi.org/10.1016/j.pediatrneurol.2016.10.006
- Zschocke J. Hoffmann, GF. Vademecum Metabolicum. 2nd. Friedrichsdorf, Germany: Milupa; 2004. p. 32
- Barshop BA. Metabolomic approaches to mitochondrial disease: correlation of urine organic acids. Mitochondrion 2004;4:521-7. https://doi.org/10.1016/j.mito.2004.07.010
- Sperl W, Jesina P, Zeman J, Mayr JA, DeMeirleir L, VanCoster R, et al. Deficiency of mitochondrial ATP synthase of nuclear genetic origin. Neuromuscul Disord 2006;16:821-9. https://doi.org/10.1016/j.nmd.2006.08.008
- Gibson KM, Sherwood WG, Hoffmann GF, Stumpf DA, Dianzanl I, Schutgens RBH, et al. Phenotypic heterogeneity in the syndromes of 3-methylglutaconic aciduria. J Pediatr 1991;118:885-90. https://doi.org/10.1016/S0022-3476(05)82199-7